Use of methylation inhibitors for the treatment of autoimmune diseases
US11992500B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2019 |
| Grant date | May 28, 2024 |
| Priority date | — |
| Expiry date | Apr 26, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein is a method for treating an autoimmune disease in a patient including administering to the patient in need thereof, a pharmaceutically effective amount of an epigenetic enzyme inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.